229 results Een herziening van de Kaderrichtlijn Water (deel XI) De KRW staat voor belangrijke veranderingen. Naast het 8ste omnibusvoorstel van de Europese Commissie is er een politiek akkoord over herziening bereikt. Dit akkoord biedt nieuwe uitzonderingen op het achteruitgangsverbod en voegt prioritaire stoffen toe. First application of Towercast in Belgium and merger filing exemption for certain hospital merger The Belgian Competition Authority has applied the Towercast case law in a first case in Belgium. It could possibly try do so again for certain hospital mergers that the legislator has recently exempted from merger filing in Belgium. On repeat but louder: the ACMâs 2024 priorities On 23 January 2024, the ACM announced its priorities for 2024. The energy transition, the digital economy and sustainability are still on the ACMâs priority list, but now with better-equipped enforcement methods available. The long and (un)winding road of âkiller acquisitionâ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a dayâs work for the European Commission. Innovation was a recurring theme in the Commissionâs handling of the Illumina/Grail deal. If you have nothing nice to sayâŚTeva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and âdivisional gamingâ to delay market entry and hinder the uptake of a competing drug. The ECJâs ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement. Stibbe advises Jumbo family Van Eerd on acquisition of Hema Stibbe advised Mississippi Ventures, the investment vehicle of the Van Eerd family (owners of supermarket chain Jumbo), on the acquisition of the remaining 50 per cent of the shares in HEMA. Stibbe adviseert Jumbo-familie Van Eerd bij overname HEMA Stibbe heeft Mississippi Ventures, het investeringsvehikel van de familie Van Eerd (eigenaar van supermarktketen Jumbo), geadviseerd bij de overname van de overige 50 procent van de aandelen in HEMA. Stibbe advises Seven2 Stibbe advised Seven2 on the acquisition of a majority stake in Zwart Techniek. Belgian Competition Authority confirms jurisdiction for M&A transactions in hospital sector On 14 July 2023, the Belgian Competition Authority confirmed its jurisdiction to review M&A transactions between hospitals, regardless of whether these hospitals belong to the same hospital network. The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests. Extended access to electronic data for the Belgian Competition Authority The Belgian legislator has amended some competition law provisions in Book IV Code of Economic law. The new provision on access to data of electronic communications operators endows the Belgian Competition Authority with new investigation powers. Pagination Previous page Page 10 Page 11 Page 12 Current page 13
Een herziening van de Kaderrichtlijn Water (deel XI) De KRW staat voor belangrijke veranderingen. Naast het 8ste omnibusvoorstel van de Europese Commissie is er een politiek akkoord over herziening bereikt. Dit akkoord biedt nieuwe uitzonderingen op het achteruitgangsverbod en voegt prioritaire stoffen toe.
First application of Towercast in Belgium and merger filing exemption for certain hospital merger The Belgian Competition Authority has applied the Towercast case law in a first case in Belgium. It could possibly try do so again for certain hospital mergers that the legislator has recently exempted from merger filing in Belgium.
On repeat but louder: the ACMâs 2024 priorities On 23 January 2024, the ACM announced its priorities for 2024. The energy transition, the digital economy and sustainability are still on the ACMâs priority list, but now with better-equipped enforcement methods available.
The long and (un)winding road of âkiller acquisitionâ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a dayâs work for the European Commission. Innovation was a recurring theme in the Commissionâs handling of the Illumina/Grail deal.
If you have nothing nice to sayâŚTeva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and âdivisional gamingâ to delay market entry and hinder the uptake of a competing drug.
The ECJâs ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.
Stibbe advises Jumbo family Van Eerd on acquisition of Hema Stibbe advised Mississippi Ventures, the investment vehicle of the Van Eerd family (owners of supermarket chain Jumbo), on the acquisition of the remaining 50 per cent of the shares in HEMA.
Stibbe adviseert Jumbo-familie Van Eerd bij overname HEMA Stibbe heeft Mississippi Ventures, het investeringsvehikel van de familie Van Eerd (eigenaar van supermarktketen Jumbo), geadviseerd bij de overname van de overige 50 procent van de aandelen in HEMA.
Stibbe advises Seven2 Stibbe advised Seven2 on the acquisition of a majority stake in Zwart Techniek.
Belgian Competition Authority confirms jurisdiction for M&A transactions in hospital sector On 14 July 2023, the Belgian Competition Authority confirmed its jurisdiction to review M&A transactions between hospitals, regardless of whether these hospitals belong to the same hospital network.
The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.
Extended access to electronic data for the Belgian Competition Authority The Belgian legislator has amended some competition law provisions in Book IV Code of Economic law. The new provision on access to data of electronic communications operators endows the Belgian Competition Authority with new investigation powers.